Global mRNA Flu Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global mRNA Flu Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Flu Vaccine Industry Forecast” looks at past sales and reviews total world mRNA Flu Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected mRNA Flu Vaccine sales for 2024 through 2030. With mRNA Flu Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Flu Vaccine industry.
This Insight Report provides a comprehensive analysis of the global mRNA Flu Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Flu Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Flu Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Flu Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Flu Vaccine.
United States market for mRNA Flu Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for mRNA Flu Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for mRNA Flu Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key mRNA Flu Vaccine players cover Moderna, BioNTech, CureVac, Novavax, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Flu Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global mRNA Flu Vaccine market?
What factors are driving mRNA Flu Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Flu Vaccine market opportunities vary by end market size?
How does mRNA Flu Vaccine break out by Type, by Application?
The global mRNA Flu Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “mRNA Flu Vaccine Industry Forecast” looks at past sales and reviews total world mRNA Flu Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected mRNA Flu Vaccine sales for 2024 through 2030. With mRNA Flu Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Flu Vaccine industry.
This Insight Report provides a comprehensive analysis of the global mRNA Flu Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Flu Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Flu Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Flu Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Flu Vaccine.
United States market for mRNA Flu Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for mRNA Flu Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for mRNA Flu Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key mRNA Flu Vaccine players cover Moderna, BioNTech, CureVac, Novavax, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Flu Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- mRNA-1010
- mRNA-1020
- mRNA-1030
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna
- BioNTech
- CureVac
- Novavax
- Sanofi
- Inovio Pharmaceuticals
- Arcturus Therapeutics Holdings
- eTheRNA immunotherapies
- Valneva
- Vaxart
- Entos Pharmaceuticals
- Abnova Corporation
- Anima Biotech
- Sarepta Therapeutics
- iBio
- Barinthus Biotherapeutics
- Alnylam Pharmaceuticals
- Beam Therapeutics
What is the 10-year outlook for the global mRNA Flu Vaccine market?
What factors are driving mRNA Flu Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Flu Vaccine market opportunities vary by end market size?
How does mRNA Flu Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Flu Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for mRNA Flu Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for mRNA Flu Vaccine by Country/Region, 2019, 2023 & 2030
2.2 mRNA Flu Vaccine Segment by Type
2.2.1 mRNA-1010
2.2.2 mRNA-1020
2.2.3 mRNA-1030
2.3 mRNA Flu Vaccine Sales by Type
2.3.1 Global mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global mRNA Flu Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global mRNA Flu Vaccine Sale Price by Type (2019-2024)
2.4 mRNA Flu Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 mRNA Flu Vaccine Sales by Application
2.5.1 Global mRNA Flu Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global mRNA Flu Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global mRNA Flu Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global mRNA Flu Vaccine Breakdown Data by Company
3.1.1 Global mRNA Flu Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global mRNA Flu Vaccine Sales Market Share by Company (2019-2024)
3.2 Global mRNA Flu Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global mRNA Flu Vaccine Revenue by Company (2019-2024)
3.2.2 Global mRNA Flu Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global mRNA Flu Vaccine Sale Price by Company
3.4 Key Manufacturers mRNA Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Flu Vaccine Product Location Distribution
3.4.2 Players mRNA Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA FLU VACCINE BY GEOGRAPHIC REGION
4.1 World Historic mRNA Flu Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global mRNA Flu Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global mRNA Flu Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic mRNA Flu Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global mRNA Flu Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global mRNA Flu Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas mRNA Flu Vaccine Sales Growth
4.4 APAC mRNA Flu Vaccine Sales Growth
4.5 Europe mRNA Flu Vaccine Sales Growth
4.6 Middle East & Africa mRNA Flu Vaccine Sales Growth
5 AMERICAS
5.1 Americas mRNA Flu Vaccine Sales by Country
5.1.1 Americas mRNA Flu Vaccine Sales by Country (2019-2024)
5.1.2 Americas mRNA Flu Vaccine Revenue by Country (2019-2024)
5.2 Americas mRNA Flu Vaccine Sales by Type (2019-2024)
5.3 Americas mRNA Flu Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Flu Vaccine Sales by Region
6.1.1 APAC mRNA Flu Vaccine Sales by Region (2019-2024)
6.1.2 APAC mRNA Flu Vaccine Revenue by Region (2019-2024)
6.2 APAC mRNA Flu Vaccine Sales by Type (2019-2024)
6.3 APAC mRNA Flu Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Flu Vaccine by Country
7.1.1 Europe mRNA Flu Vaccine Sales by Country (2019-2024)
7.1.2 Europe mRNA Flu Vaccine Revenue by Country (2019-2024)
7.2 Europe mRNA Flu Vaccine Sales by Type (2019-2024)
7.3 Europe mRNA Flu Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Flu Vaccine by Country
8.1.1 Middle East & Africa mRNA Flu Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa mRNA Flu Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa mRNA Flu Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa mRNA Flu Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Flu Vaccine
10.3 Manufacturing Process Analysis of mRNA Flu Vaccine
10.4 Industry Chain Structure of mRNA Flu Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Flu Vaccine Distributors
11.3 mRNA Flu Vaccine Customer
12 WORLD FORECAST REVIEW FOR MRNA FLU VACCINE BY GEOGRAPHIC REGION
12.1 Global mRNA Flu Vaccine Market Size Forecast by Region
12.1.1 Global mRNA Flu Vaccine Forecast by Region (2025-2030)
12.1.2 Global mRNA Flu Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global mRNA Flu Vaccine Forecast by Type (2025-2030)
12.7 Global mRNA Flu Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna mRNA Flu Vaccine Product Portfolios and Specifications
13.1.3 Moderna mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 BioNTech
13.2.1 BioNTech Company Information
13.2.2 BioNTech mRNA Flu Vaccine Product Portfolios and Specifications
13.2.3 BioNTech mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BioNTech Main Business Overview
13.2.5 BioNTech Latest Developments
13.3 CureVac
13.3.1 CureVac Company Information
13.3.2 CureVac mRNA Flu Vaccine Product Portfolios and Specifications
13.3.3 CureVac mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CureVac Main Business Overview
13.3.5 CureVac Latest Developments
13.4 Novavax
13.4.1 Novavax Company Information
13.4.2 Novavax mRNA Flu Vaccine Product Portfolios and Specifications
13.4.3 Novavax mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Novavax Main Business Overview
13.4.5 Novavax Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi mRNA Flu Vaccine Product Portfolios and Specifications
13.5.3 Sanofi mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Inovio Pharmaceuticals
13.6.1 Inovio Pharmaceuticals Company Information
13.6.2 Inovio Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
13.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Inovio Pharmaceuticals Main Business Overview
13.6.5 Inovio Pharmaceuticals Latest Developments
13.7 Arcturus Therapeutics Holdings
13.7.1 Arcturus Therapeutics Holdings Company Information
13.7.2 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Portfolios and Specifications
13.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Arcturus Therapeutics Holdings Main Business Overview
13.7.5 Arcturus Therapeutics Holdings Latest Developments
13.8 eTheRNA immunotherapies
13.8.1 eTheRNA immunotherapies Company Information
13.8.2 eTheRNA immunotherapies mRNA Flu Vaccine Product Portfolios and Specifications
13.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 eTheRNA immunotherapies Main Business Overview
13.8.5 eTheRNA immunotherapies Latest Developments
13.9 Valneva
13.9.1 Valneva Company Information
13.9.2 Valneva mRNA Flu Vaccine Product Portfolios and Specifications
13.9.3 Valneva mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Valneva Main Business Overview
13.9.5 Valneva Latest Developments
13.10 Vaxart
13.10.1 Vaxart Company Information
13.10.2 Vaxart mRNA Flu Vaccine Product Portfolios and Specifications
13.10.3 Vaxart mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vaxart Main Business Overview
13.10.5 Vaxart Latest Developments
13.11 Entos Pharmaceuticals
13.11.1 Entos Pharmaceuticals Company Information
13.11.2 Entos Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
13.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Entos Pharmaceuticals Main Business Overview
13.11.5 Entos Pharmaceuticals Latest Developments
13.12 Abnova Corporation
13.12.1 Abnova Corporation Company Information
13.12.2 Abnova Corporation mRNA Flu Vaccine Product Portfolios and Specifications
13.12.3 Abnova Corporation mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Abnova Corporation Main Business Overview
13.12.5 Abnova Corporation Latest Developments
13.13 Anima Biotech
13.13.1 Anima Biotech Company Information
13.13.2 Anima Biotech mRNA Flu Vaccine Product Portfolios and Specifications
13.13.3 Anima Biotech mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Anima Biotech Main Business Overview
13.13.5 Anima Biotech Latest Developments
13.14 Sarepta Therapeutics
13.14.1 Sarepta Therapeutics Company Information
13.14.2 Sarepta Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
13.14.3 Sarepta Therapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sarepta Therapeutics Main Business Overview
13.14.5 Sarepta Therapeutics Latest Developments
13.15 iBio
13.15.1 iBio Company Information
13.15.2 iBio mRNA Flu Vaccine Product Portfolios and Specifications
13.15.3 iBio mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 iBio Main Business Overview
13.15.5 iBio Latest Developments
13.16 Barinthus Biotherapeutics
13.16.1 Barinthus Biotherapeutics Company Information
13.16.2 Barinthus Biotherapeutics mRNA Flu Vaccine Product Portfolios and Specifications
13.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Barinthus Biotherapeutics Main Business Overview
13.16.5 Barinthus Biotherapeutics Latest Developments
13.17 Alnylam Pharmaceuticals
13.17.1 Alnylam Pharmaceuticals Company Information
13.17.2 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
13.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Alnylam Pharmaceuticals Main Business Overview
13.17.5 Alnylam Pharmaceuticals Latest Developments
13.18 Beam Therapeutics
13.18.1 Beam Therapeutics Company Information
13.18.2 Beam Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
13.18.3 Beam Therapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Beam Therapeutics Main Business Overview
13.18.5 Beam Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Flu Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for mRNA Flu Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for mRNA Flu Vaccine by Country/Region, 2019, 2023 & 2030
2.2 mRNA Flu Vaccine Segment by Type
2.2.1 mRNA-1010
2.2.2 mRNA-1020
2.2.3 mRNA-1030
2.3 mRNA Flu Vaccine Sales by Type
2.3.1 Global mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global mRNA Flu Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global mRNA Flu Vaccine Sale Price by Type (2019-2024)
2.4 mRNA Flu Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 mRNA Flu Vaccine Sales by Application
2.5.1 Global mRNA Flu Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global mRNA Flu Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global mRNA Flu Vaccine Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global mRNA Flu Vaccine Breakdown Data by Company
3.1.1 Global mRNA Flu Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global mRNA Flu Vaccine Sales Market Share by Company (2019-2024)
3.2 Global mRNA Flu Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global mRNA Flu Vaccine Revenue by Company (2019-2024)
3.2.2 Global mRNA Flu Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global mRNA Flu Vaccine Sale Price by Company
3.4 Key Manufacturers mRNA Flu Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Flu Vaccine Product Location Distribution
3.4.2 Players mRNA Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MRNA FLU VACCINE BY GEOGRAPHIC REGION
4.1 World Historic mRNA Flu Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global mRNA Flu Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global mRNA Flu Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic mRNA Flu Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global mRNA Flu Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global mRNA Flu Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas mRNA Flu Vaccine Sales Growth
4.4 APAC mRNA Flu Vaccine Sales Growth
4.5 Europe mRNA Flu Vaccine Sales Growth
4.6 Middle East & Africa mRNA Flu Vaccine Sales Growth
5 AMERICAS
5.1 Americas mRNA Flu Vaccine Sales by Country
5.1.1 Americas mRNA Flu Vaccine Sales by Country (2019-2024)
5.1.2 Americas mRNA Flu Vaccine Revenue by Country (2019-2024)
5.2 Americas mRNA Flu Vaccine Sales by Type (2019-2024)
5.3 Americas mRNA Flu Vaccine Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Flu Vaccine Sales by Region
6.1.1 APAC mRNA Flu Vaccine Sales by Region (2019-2024)
6.1.2 APAC mRNA Flu Vaccine Revenue by Region (2019-2024)
6.2 APAC mRNA Flu Vaccine Sales by Type (2019-2024)
6.3 APAC mRNA Flu Vaccine Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Flu Vaccine by Country
7.1.1 Europe mRNA Flu Vaccine Sales by Country (2019-2024)
7.1.2 Europe mRNA Flu Vaccine Revenue by Country (2019-2024)
7.2 Europe mRNA Flu Vaccine Sales by Type (2019-2024)
7.3 Europe mRNA Flu Vaccine Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Flu Vaccine by Country
8.1.1 Middle East & Africa mRNA Flu Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa mRNA Flu Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa mRNA Flu Vaccine Sales by Type (2019-2024)
8.3 Middle East & Africa mRNA Flu Vaccine Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Flu Vaccine
10.3 Manufacturing Process Analysis of mRNA Flu Vaccine
10.4 Industry Chain Structure of mRNA Flu Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Flu Vaccine Distributors
11.3 mRNA Flu Vaccine Customer
12 WORLD FORECAST REVIEW FOR MRNA FLU VACCINE BY GEOGRAPHIC REGION
12.1 Global mRNA Flu Vaccine Market Size Forecast by Region
12.1.1 Global mRNA Flu Vaccine Forecast by Region (2025-2030)
12.1.2 Global mRNA Flu Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global mRNA Flu Vaccine Forecast by Type (2025-2030)
12.7 Global mRNA Flu Vaccine Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Moderna
13.1.1 Moderna Company Information
13.1.2 Moderna mRNA Flu Vaccine Product Portfolios and Specifications
13.1.3 Moderna mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Moderna Main Business Overview
13.1.5 Moderna Latest Developments
13.2 BioNTech
13.2.1 BioNTech Company Information
13.2.2 BioNTech mRNA Flu Vaccine Product Portfolios and Specifications
13.2.3 BioNTech mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BioNTech Main Business Overview
13.2.5 BioNTech Latest Developments
13.3 CureVac
13.3.1 CureVac Company Information
13.3.2 CureVac mRNA Flu Vaccine Product Portfolios and Specifications
13.3.3 CureVac mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CureVac Main Business Overview
13.3.5 CureVac Latest Developments
13.4 Novavax
13.4.1 Novavax Company Information
13.4.2 Novavax mRNA Flu Vaccine Product Portfolios and Specifications
13.4.3 Novavax mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Novavax Main Business Overview
13.4.5 Novavax Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi mRNA Flu Vaccine Product Portfolios and Specifications
13.5.3 Sanofi mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Inovio Pharmaceuticals
13.6.1 Inovio Pharmaceuticals Company Information
13.6.2 Inovio Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
13.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Inovio Pharmaceuticals Main Business Overview
13.6.5 Inovio Pharmaceuticals Latest Developments
13.7 Arcturus Therapeutics Holdings
13.7.1 Arcturus Therapeutics Holdings Company Information
13.7.2 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Portfolios and Specifications
13.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Arcturus Therapeutics Holdings Main Business Overview
13.7.5 Arcturus Therapeutics Holdings Latest Developments
13.8 eTheRNA immunotherapies
13.8.1 eTheRNA immunotherapies Company Information
13.8.2 eTheRNA immunotherapies mRNA Flu Vaccine Product Portfolios and Specifications
13.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 eTheRNA immunotherapies Main Business Overview
13.8.5 eTheRNA immunotherapies Latest Developments
13.9 Valneva
13.9.1 Valneva Company Information
13.9.2 Valneva mRNA Flu Vaccine Product Portfolios and Specifications
13.9.3 Valneva mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Valneva Main Business Overview
13.9.5 Valneva Latest Developments
13.10 Vaxart
13.10.1 Vaxart Company Information
13.10.2 Vaxart mRNA Flu Vaccine Product Portfolios and Specifications
13.10.3 Vaxart mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vaxart Main Business Overview
13.10.5 Vaxart Latest Developments
13.11 Entos Pharmaceuticals
13.11.1 Entos Pharmaceuticals Company Information
13.11.2 Entos Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
13.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Entos Pharmaceuticals Main Business Overview
13.11.5 Entos Pharmaceuticals Latest Developments
13.12 Abnova Corporation
13.12.1 Abnova Corporation Company Information
13.12.2 Abnova Corporation mRNA Flu Vaccine Product Portfolios and Specifications
13.12.3 Abnova Corporation mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Abnova Corporation Main Business Overview
13.12.5 Abnova Corporation Latest Developments
13.13 Anima Biotech
13.13.1 Anima Biotech Company Information
13.13.2 Anima Biotech mRNA Flu Vaccine Product Portfolios and Specifications
13.13.3 Anima Biotech mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Anima Biotech Main Business Overview
13.13.5 Anima Biotech Latest Developments
13.14 Sarepta Therapeutics
13.14.1 Sarepta Therapeutics Company Information
13.14.2 Sarepta Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
13.14.3 Sarepta Therapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sarepta Therapeutics Main Business Overview
13.14.5 Sarepta Therapeutics Latest Developments
13.15 iBio
13.15.1 iBio Company Information
13.15.2 iBio mRNA Flu Vaccine Product Portfolios and Specifications
13.15.3 iBio mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 iBio Main Business Overview
13.15.5 iBio Latest Developments
13.16 Barinthus Biotherapeutics
13.16.1 Barinthus Biotherapeutics Company Information
13.16.2 Barinthus Biotherapeutics mRNA Flu Vaccine Product Portfolios and Specifications
13.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Barinthus Biotherapeutics Main Business Overview
13.16.5 Barinthus Biotherapeutics Latest Developments
13.17 Alnylam Pharmaceuticals
13.17.1 Alnylam Pharmaceuticals Company Information
13.17.2 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
13.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Alnylam Pharmaceuticals Main Business Overview
13.17.5 Alnylam Pharmaceuticals Latest Developments
13.18 Beam Therapeutics
13.18.1 Beam Therapeutics Company Information
13.18.2 Beam Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
13.18.3 Beam Therapeutics mRNA Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Beam Therapeutics Main Business Overview
13.18.5 Beam Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Flu Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. mRNA Flu Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of mRNA-1010
Table 4. Major Players of mRNA-1020
Table 5. Major Players of mRNA-1030
Table 6. Global mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 7. Global mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global mRNA Flu Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global mRNA Flu Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global mRNA Flu Vaccine Sale by Application (2019-2024) & (K Units)
Table 12. Global mRNA Flu Vaccine Sale Market Share by Application (2019-2024)
Table 13. Global mRNA Flu Vaccine Revenue by Application (2019-2024) & ($ million)
Table 14. Global mRNA Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global mRNA Flu Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global mRNA Flu Vaccine Sales by Company (2019-2024) & (K Units)
Table 17. Global mRNA Flu Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global mRNA Flu Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 19. Global mRNA Flu Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global mRNA Flu Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers mRNA Flu Vaccine Producing Area Distribution and Sales Area
Table 22. Players mRNA Flu Vaccine Products Offered
Table 23. mRNA Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global mRNA Flu Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global mRNA Flu Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global mRNA Flu Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global mRNA Flu Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global mRNA Flu Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global mRNA Flu Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global mRNA Flu Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global mRNA Flu Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 35. Americas mRNA Flu Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas mRNA Flu Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC mRNA Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC mRNA Flu Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC mRNA Flu Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 43. APAC mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 44. Europe mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 45. Europe mRNA Flu Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 47. Europe mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa mRNA Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of mRNA Flu Vaccine
Table 53. Key Market Challenges & Risks of mRNA Flu Vaccine
Table 54. Key Industry Trends of mRNA Flu Vaccine
Table 55. mRNA Flu Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. mRNA Flu Vaccine Distributors List
Table 58. mRNA Flu Vaccine Customer List
Table 59. Global mRNA Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global mRNA Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas mRNA Flu Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC mRNA Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC mRNA Flu Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe mRNA Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa mRNA Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global mRNA Flu Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global mRNA Flu Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global mRNA Flu Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global mRNA Flu Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Moderna Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Moderna mRNA Flu Vaccine Product Portfolios and Specifications
Table 75. Moderna mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Moderna Main Business
Table 77. Moderna Latest Developments
Table 78. BioNTech Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. BioNTech mRNA Flu Vaccine Product Portfolios and Specifications
Table 80. BioNTech mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. BioNTech Main Business
Table 82. BioNTech Latest Developments
Table 83. CureVac Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CureVac mRNA Flu Vaccine Product Portfolios and Specifications
Table 85. CureVac mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CureVac Main Business
Table 87. CureVac Latest Developments
Table 88. Novavax Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novavax mRNA Flu Vaccine Product Portfolios and Specifications
Table 90. Novavax mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Novavax Main Business
Table 92. Novavax Latest Developments
Table 93. Sanofi Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi mRNA Flu Vaccine Product Portfolios and Specifications
Table 95. Sanofi mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Inovio Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Inovio Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
Table 100. Inovio Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Inovio Pharmaceuticals Main Business
Table 102. Inovio Pharmaceuticals Latest Developments
Table 103. Arcturus Therapeutics Holdings Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Portfolios and Specifications
Table 105. Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Arcturus Therapeutics Holdings Main Business
Table 107. Arcturus Therapeutics Holdings Latest Developments
Table 108. eTheRNA immunotherapies Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. eTheRNA immunotherapies mRNA Flu Vaccine Product Portfolios and Specifications
Table 110. eTheRNA immunotherapies mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. eTheRNA immunotherapies Main Business
Table 112. eTheRNA immunotherapies Latest Developments
Table 113. Valneva Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Valneva mRNA Flu Vaccine Product Portfolios and Specifications
Table 115. Valneva mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Valneva Main Business
Table 117. Valneva Latest Developments
Table 118. Vaxart Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Vaxart mRNA Flu Vaccine Product Portfolios and Specifications
Table 120. Vaxart mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Vaxart Main Business
Table 122. Vaxart Latest Developments
Table 123. Entos Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Entos Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
Table 125. Entos Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Entos Pharmaceuticals Main Business
Table 127. Entos Pharmaceuticals Latest Developments
Table 128. Abnova Corporation Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Abnova Corporation mRNA Flu Vaccine Product Portfolios and Specifications
Table 130. Abnova Corporation mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Abnova Corporation Main Business
Table 132. Abnova Corporation Latest Developments
Table 133. Anima Biotech Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Anima Biotech mRNA Flu Vaccine Product Portfolios and Specifications
Table 135. Anima Biotech mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Anima Biotech Main Business
Table 137. Anima Biotech Latest Developments
Table 138. Sarepta Therapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Sarepta Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
Table 140. Sarepta Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Sarepta Therapeutics Main Business
Table 142. Sarepta Therapeutics Latest Developments
Table 143. iBio Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. iBio mRNA Flu Vaccine Product Portfolios and Specifications
Table 145. iBio mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. iBio Main Business
Table 147. iBio Latest Developments
Table 148. Barinthus Biotherapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Barinthus Biotherapeutics mRNA Flu Vaccine Product Portfolios and Specifications
Table 150. Barinthus Biotherapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. Barinthus Biotherapeutics Main Business
Table 152. Barinthus Biotherapeutics Latest Developments
Table 153. Alnylam Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Alnylam Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
Table 155. Alnylam Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 156. Alnylam Pharmaceuticals Main Business
Table 157. Alnylam Pharmaceuticals Latest Developments
Table 158. Beam Therapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Beam Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
Table 160. Beam Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 161. Beam Therapeutics Main Business
Table 162. Beam Therapeutics Latest Developments
Table 1. mRNA Flu Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. mRNA Flu Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of mRNA-1010
Table 4. Major Players of mRNA-1020
Table 5. Major Players of mRNA-1030
Table 6. Global mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 7. Global mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global mRNA Flu Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global mRNA Flu Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global mRNA Flu Vaccine Sale by Application (2019-2024) & (K Units)
Table 12. Global mRNA Flu Vaccine Sale Market Share by Application (2019-2024)
Table 13. Global mRNA Flu Vaccine Revenue by Application (2019-2024) & ($ million)
Table 14. Global mRNA Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global mRNA Flu Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global mRNA Flu Vaccine Sales by Company (2019-2024) & (K Units)
Table 17. Global mRNA Flu Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global mRNA Flu Vaccine Revenue by Company (2019-2024) & ($ millions)
Table 19. Global mRNA Flu Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global mRNA Flu Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers mRNA Flu Vaccine Producing Area Distribution and Sales Area
Table 22. Players mRNA Flu Vaccine Products Offered
Table 23. mRNA Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global mRNA Flu Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global mRNA Flu Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global mRNA Flu Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global mRNA Flu Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global mRNA Flu Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global mRNA Flu Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global mRNA Flu Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global mRNA Flu Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 35. Americas mRNA Flu Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas mRNA Flu Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC mRNA Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC mRNA Flu Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC mRNA Flu Vaccine Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 43. APAC mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 44. Europe mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 45. Europe mRNA Flu Vaccine Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 47. Europe mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa mRNA Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa mRNA Flu Vaccine Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa mRNA Flu Vaccine Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of mRNA Flu Vaccine
Table 53. Key Market Challenges & Risks of mRNA Flu Vaccine
Table 54. Key Industry Trends of mRNA Flu Vaccine
Table 55. mRNA Flu Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. mRNA Flu Vaccine Distributors List
Table 58. mRNA Flu Vaccine Customer List
Table 59. Global mRNA Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global mRNA Flu Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas mRNA Flu Vaccine Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC mRNA Flu Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC mRNA Flu Vaccine Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe mRNA Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa mRNA Flu Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa mRNA Flu Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global mRNA Flu Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global mRNA Flu Vaccine Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global mRNA Flu Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global mRNA Flu Vaccine Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Moderna Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Moderna mRNA Flu Vaccine Product Portfolios and Specifications
Table 75. Moderna mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Moderna Main Business
Table 77. Moderna Latest Developments
Table 78. BioNTech Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. BioNTech mRNA Flu Vaccine Product Portfolios and Specifications
Table 80. BioNTech mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. BioNTech Main Business
Table 82. BioNTech Latest Developments
Table 83. CureVac Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CureVac mRNA Flu Vaccine Product Portfolios and Specifications
Table 85. CureVac mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CureVac Main Business
Table 87. CureVac Latest Developments
Table 88. Novavax Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novavax mRNA Flu Vaccine Product Portfolios and Specifications
Table 90. Novavax mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Novavax Main Business
Table 92. Novavax Latest Developments
Table 93. Sanofi Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi mRNA Flu Vaccine Product Portfolios and Specifications
Table 95. Sanofi mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Inovio Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Inovio Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
Table 100. Inovio Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Inovio Pharmaceuticals Main Business
Table 102. Inovio Pharmaceuticals Latest Developments
Table 103. Arcturus Therapeutics Holdings Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Portfolios and Specifications
Table 105. Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Arcturus Therapeutics Holdings Main Business
Table 107. Arcturus Therapeutics Holdings Latest Developments
Table 108. eTheRNA immunotherapies Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. eTheRNA immunotherapies mRNA Flu Vaccine Product Portfolios and Specifications
Table 110. eTheRNA immunotherapies mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. eTheRNA immunotherapies Main Business
Table 112. eTheRNA immunotherapies Latest Developments
Table 113. Valneva Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Valneva mRNA Flu Vaccine Product Portfolios and Specifications
Table 115. Valneva mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Valneva Main Business
Table 117. Valneva Latest Developments
Table 118. Vaxart Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Vaxart mRNA Flu Vaccine Product Portfolios and Specifications
Table 120. Vaxart mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Vaxart Main Business
Table 122. Vaxart Latest Developments
Table 123. Entos Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Entos Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
Table 125. Entos Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Entos Pharmaceuticals Main Business
Table 127. Entos Pharmaceuticals Latest Developments
Table 128. Abnova Corporation Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Abnova Corporation mRNA Flu Vaccine Product Portfolios and Specifications
Table 130. Abnova Corporation mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Abnova Corporation Main Business
Table 132. Abnova Corporation Latest Developments
Table 133. Anima Biotech Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Anima Biotech mRNA Flu Vaccine Product Portfolios and Specifications
Table 135. Anima Biotech mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Anima Biotech Main Business
Table 137. Anima Biotech Latest Developments
Table 138. Sarepta Therapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Sarepta Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
Table 140. Sarepta Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Sarepta Therapeutics Main Business
Table 142. Sarepta Therapeutics Latest Developments
Table 143. iBio Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. iBio mRNA Flu Vaccine Product Portfolios and Specifications
Table 145. iBio mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. iBio Main Business
Table 147. iBio Latest Developments
Table 148. Barinthus Biotherapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Barinthus Biotherapeutics mRNA Flu Vaccine Product Portfolios and Specifications
Table 150. Barinthus Biotherapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. Barinthus Biotherapeutics Main Business
Table 152. Barinthus Biotherapeutics Latest Developments
Table 153. Alnylam Pharmaceuticals Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Alnylam Pharmaceuticals mRNA Flu Vaccine Product Portfolios and Specifications
Table 155. Alnylam Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 156. Alnylam Pharmaceuticals Main Business
Table 157. Alnylam Pharmaceuticals Latest Developments
Table 158. Beam Therapeutics Basic Information, mRNA Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Beam Therapeutics mRNA Flu Vaccine Product Portfolios and Specifications
Table 160. Beam Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 161. Beam Therapeutics Main Business
Table 162. Beam Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of mRNA Flu Vaccine
Figure 2. mRNA Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Flu Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global mRNA Flu Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. mRNA Flu Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. mRNA Flu Vaccine Sales Market Share by Country/Region (2023)
Figure 10. mRNA Flu Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of mRNA-1010
Figure 12. Product Picture of mRNA-1020
Figure 13. Product Picture of mRNA-1030
Figure 14. Global mRNA Flu Vaccine Sales Market Share by Type in 2023
Figure 15. Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2024)
Figure 16. mRNA Flu Vaccine Consumed in Hospital
Figure 17. Global mRNA Flu Vaccine Market: Hospital (2019-2024) & (K Units)
Figure 18. mRNA Flu Vaccine Consumed in Clinic
Figure 19. Global mRNA Flu Vaccine Market: Clinic (2019-2024) & (K Units)
Figure 20. mRNA Flu Vaccine Consumed in Other
Figure 21. Global mRNA Flu Vaccine Market: Other (2019-2024) & (K Units)
Figure 22. Global mRNA Flu Vaccine Sale Market Share by Application (2023)
Figure 23. Global mRNA Flu Vaccine Revenue Market Share by Application in 2023
Figure 24. mRNA Flu Vaccine Sales by Company in 2023 (K Units)
Figure 25. Global mRNA Flu Vaccine Sales Market Share by Company in 2023
Figure 26. mRNA Flu Vaccine Revenue by Company in 2023 ($ millions)
Figure 27. Global mRNA Flu Vaccine Revenue Market Share by Company in 2023
Figure 28. Global mRNA Flu Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global mRNA Flu Vaccine Revenue Market Share by Geographic Region in 2023
Figure 30. Americas mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 31. Americas mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 32. APAC mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 33. APAC mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 34. Europe mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 35. Europe mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 38. Americas mRNA Flu Vaccine Sales Market Share by Country in 2023
Figure 39. Americas mRNA Flu Vaccine Revenue Market Share by Country (2019-2024)
Figure 40. Americas mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 41. Americas mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 42. United States mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC mRNA Flu Vaccine Sales Market Share by Region in 2023
Figure 47. APAC mRNA Flu Vaccine Revenue Market Share by Region (2019-2024)
Figure 48. APAC mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 49. APAC mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 50. China mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. India mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe mRNA Flu Vaccine Sales Market Share by Country in 2023
Figure 58. Europe mRNA Flu Vaccine Revenue Market Share by Country (2019-2024)
Figure 59. Europe mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 60. Europe mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 61. Germany mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. France mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. UK mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 69. Egypt mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of mRNA Flu Vaccine in 2023
Figure 75. Manufacturing Process Analysis of mRNA Flu Vaccine
Figure 76. Industry Chain Structure of mRNA Flu Vaccine
Figure 77. Channels of Distribution
Figure 78. Global mRNA Flu Vaccine Sales Market Forecast by Region (2025-2030)
Figure 79. Global mRNA Flu Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global mRNA Flu Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global mRNA Flu Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global mRNA Flu Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global mRNA Flu Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of mRNA Flu Vaccine
Figure 2. mRNA Flu Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Flu Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global mRNA Flu Vaccine Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. mRNA Flu Vaccine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. mRNA Flu Vaccine Sales Market Share by Country/Region (2023)
Figure 10. mRNA Flu Vaccine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of mRNA-1010
Figure 12. Product Picture of mRNA-1020
Figure 13. Product Picture of mRNA-1030
Figure 14. Global mRNA Flu Vaccine Sales Market Share by Type in 2023
Figure 15. Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2024)
Figure 16. mRNA Flu Vaccine Consumed in Hospital
Figure 17. Global mRNA Flu Vaccine Market: Hospital (2019-2024) & (K Units)
Figure 18. mRNA Flu Vaccine Consumed in Clinic
Figure 19. Global mRNA Flu Vaccine Market: Clinic (2019-2024) & (K Units)
Figure 20. mRNA Flu Vaccine Consumed in Other
Figure 21. Global mRNA Flu Vaccine Market: Other (2019-2024) & (K Units)
Figure 22. Global mRNA Flu Vaccine Sale Market Share by Application (2023)
Figure 23. Global mRNA Flu Vaccine Revenue Market Share by Application in 2023
Figure 24. mRNA Flu Vaccine Sales by Company in 2023 (K Units)
Figure 25. Global mRNA Flu Vaccine Sales Market Share by Company in 2023
Figure 26. mRNA Flu Vaccine Revenue by Company in 2023 ($ millions)
Figure 27. Global mRNA Flu Vaccine Revenue Market Share by Company in 2023
Figure 28. Global mRNA Flu Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global mRNA Flu Vaccine Revenue Market Share by Geographic Region in 2023
Figure 30. Americas mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 31. Americas mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 32. APAC mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 33. APAC mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 34. Europe mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 35. Europe mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa mRNA Flu Vaccine Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa mRNA Flu Vaccine Revenue 2019-2024 ($ millions)
Figure 38. Americas mRNA Flu Vaccine Sales Market Share by Country in 2023
Figure 39. Americas mRNA Flu Vaccine Revenue Market Share by Country (2019-2024)
Figure 40. Americas mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 41. Americas mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 42. United States mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC mRNA Flu Vaccine Sales Market Share by Region in 2023
Figure 47. APAC mRNA Flu Vaccine Revenue Market Share by Region (2019-2024)
Figure 48. APAC mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 49. APAC mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 50. China mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 54. India mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe mRNA Flu Vaccine Sales Market Share by Country in 2023
Figure 58. Europe mRNA Flu Vaccine Revenue Market Share by Country (2019-2024)
Figure 59. Europe mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 60. Europe mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 61. Germany mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 62. France mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 63. UK mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Figure 69. Egypt mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries mRNA Flu Vaccine Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of mRNA Flu Vaccine in 2023
Figure 75. Manufacturing Process Analysis of mRNA Flu Vaccine
Figure 76. Industry Chain Structure of mRNA Flu Vaccine
Figure 77. Channels of Distribution
Figure 78. Global mRNA Flu Vaccine Sales Market Forecast by Region (2025-2030)
Figure 79. Global mRNA Flu Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global mRNA Flu Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global mRNA Flu Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global mRNA Flu Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global mRNA Flu Vaccine Revenue Market Share Forecast by Application (2025-2030)
